SAN FRANCISCO–(BUSINESS WIRE)–BigBio Communications, developer of the life science industry news aggregator Big4Bio, proudly announces the launch of The BioCalendar (TheBioCalendar.com), an exclusive event listing platform for the global healthcare and biopharmaceutical industry. The BioCalendar was created to be the comprehensive calendar and guide for healthcare and life science industry event attendees worldwide, and also […]
Spotlight Q&A: Outlook Therapeutics — Developing First Ophthalmic Formulation of Bevacizumab for FDA Approval
/ big4bio
LaVoieHealthScience Client Spotlight Following is a Q&A with Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics (NASDAQ: OTLK), a late-stage clinical biotech company focused on developing the first FDA-approved ophthalmic formulation of bevacizumab-vikg to treat wet age-related macular degeneration (wet AMD) and other retinal diseases. By way of background for our readers, age-related macular […]
Win a year of free lab space at LabCentral!
/ big4bio
OFFICIAL RULES
Spotlight: Moving Towards a More Inclusive Life Sciences Industry
/ big4bio
Get access to an ED&I toolkit from MassBio As our CEO, Tilton Little, was one of the 160+ life sciences CEOs that signed MassBio’s CEO Pledge for a More Equitable and Inclusive Life Sciences Industry, Big4Bio will work towards creating a more diverse life sciences industry. MassBio can help your company launch, analyze, and/or strengthen […]
Big4Bio-Area Companies Awarded NIH COVID-19 Test Contracts
/ big4bio
From the NIH: “The National Institutes of Health is investing $248.7 million in new technologies to address challenges associated with COVID-19 testing (which detects SARS-CoV-2 coronavirus). NIH’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies to support a range of new lab-based and point-of-care tests that could significantly increase […]
Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics
/ big4bio
LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]
Spotlight: 3.0 University Place
/ big4bio
“In many ways, this project (3.0 University Place) is the most responsive to the needs of Philly’s burgeoning biotech and advanced life sciences sector” – 2020 PIDC/Commerce Department Life Science Report About 3.0 University Place: 3.0 University Place — a 250,000+ sq ft, life sciences-enabled building (commercial lab and office trophy building) with LEED […]
Spotlight: Sikich — A Formula for Life Science Success
/ big4bio
Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]
Spotlight: Explora BioLabs — Powering Your Science
/ big4bio
Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]
Spotlight: Cerevance Raises $45 Million to Advance Therapeutics Against Novel CNS Targets
/ big4bio
by Marie Daghlian Cerevance has raised $45 million in a series B financing to continue deploying its platform to identify novel therapeutic targets for central nervous system diseases, and advance a pipeline of therapies for Parkinson’s disease, Alzheimer’s disease, and neuroinflammation. New investors GV, Bill Gates, and Foresite Capital joined previous investors Takeda Ventures, the […]
Big4Bio:SFBay COVID-19 Resource Page
/ big4bio
With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]
GigaGen Focuses Its Technology to Address COVID-19 Pandemic
/ big4bio
by Marie Daghlian GigaGen announced that it is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19, the pandemic coronavirus that has been sweeping the world and for which humans have no innate immunity. Based in South San Francisco, GigaGen spent the first seven years of its existence developing its single cell technology […]
RESI’s First Digital Conference Successful
/ big4bio
by Marie Daghlian The global COVID-19 pandemic has changed life as we know it, severely curtailing local and global travel, and postponing or cancelling many conferences and meetings around the world. For the RESI conference organizer Life Science Nation (LSN), however, it has presented an opportunity to go digital, and in fact, after they made […]
Big4Bio:Philadelphia COVID-19 Resource Page
/ big4bio
With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]
Big4Bio:Boston COVID-19 Resource Page
/ big4bio
With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]